Back Bay Life Science Report
by Jonathan P. Gertler and Peter Bak
November 9, 2024 12:53 am
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.
Recent Episodes
The Optimism of Bispecific Antibodies
1 week agoDynamics in Healthcare Focused Markets
2 months agoFrom NASH to MASH: Current Market Dynamics in Hepatology
2 months agoKey Considerations for a US Healthcare IPO
6 months agoDrug Development in Obesity
7 months agoThe Current Dynamics in Capital Markets
7 months agoVaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments
8 months agoTrends and Investment Activity in Radiopharmaceuticals and Psychedelics
9 months agoVertex’s Exa-cel to Biogen and Sage’s Zurzuvae: Notable Product Approvals of 2023
11 months agoMonthly Roundup of News from Healthcare Development
1 year ago